Skip to main content
SpringerLink
Log in
Book cover

European Instructional Lectures pp 3–13Cite as

Evidence for Medical Treatment for Tertiary Prophylaxis of Osteoporosis

  • Chapter
  • First Online:

  • 1184 Accesses

Part of the book series: European Instructional Lectures ((EICL,volume 13))

Abstract

Fracture Prevention Programmes have been shown to increase both the number of patients offered bone scans and the uptake of pharmaceutical therapy, thus potentially reducing the number of further fractures. Cost-effectiveness analyses suggest that such programmes may be net cost-saving. We recommend that Fracture Prevention Programmes be developed and implemented to ensure that patients presenting with fractures are offered diagnosis and treatment for osteoporosis.

Low-energy fractures are very frequent in the elderly population and are in part caused by osteoporosis. Previous fractures and low bone mineral density increase the risk of further fractures, but the available anti-osteoporosis drugs are only infrequently used in patients with recent fractures. Approximately 11–23 % of women and 3–10 % of men will suffer a hip fracture after the age of 50 years. Low-energy fractures are caused in part by osteoporosis. In Denmark, this condition affects approximately 40 % of women and 18 % of men over 50 years of age. Previous fractures and low bone mineral density increase the risk of further fractures. Among patients presenting with a hip fracture, approximately 9 % will suffer a new hip fracture within a year and approximately 20 % within 5 years. Randomized placebo-controlled trials have documented that drug treatments such as calcium plus vitamin D, oestrogen plus progestin, bisphosphonates (e.g. alendronate, risedronate, ibandronate, zoledronic acid), strontium ranelate, denosumab, teriparatide and parathyroid hormone (1-84) reduce the risk of fractures in patients with osteoporosis. Patients with recent fractures, and hip fractures in particular, are rarely offered diagnostic work-up and treatment for osteoporosis, however. Several Fracture Prevention Programmes have been tested in an attempt to overcome these problems. Studies have shown that such programs increase both the number of patients offered bone scans and the uptake of drug treatments, thus potentially reducing the number of further fractures. Cost-effectiveness analyses suggest that such programmes are likely to be net cost-saving. We recommend that Fracture Prevention Programmes be developed and implemented to ensure that patients presenting with fractures are offered diagnosis and treatment for osteoporosis. Moreover, we suggest that performance of such programmes is continuously monitored.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Notes

  1. 1.

    T-score is calculated from the patient’s bone mineral ­density (BMDpatient), the mean BMD of young ­persons of the same sex (BMDyoung-normal) and the standard ­deviation of BMD in the normal ­population (SD), using the ­formula: \( \text{T}-\text{score}=({\text{BMD}}_{\text{patient}}-{\text{BMD}}_{\text{young-normal}})/\text{SD}\).

References

  1. van Staa TP, Dennison EM, Leufkens HG, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29(6):517–522. Epub 2001/12/01

    Article  PubMed  Google Scholar 

  2. Cummings SR, Black DM, Rubin SM (1989) Lifetime risks of hip, Colles’, or vertebral fracture and coronary heart disease among white postmenopausal women. Arch Intern Med 149(11):2445–2448. Epub 1989/11/01

    Article  PubMed  CAS  Google Scholar 

  3. Kanis JA, Johnell O, Oden A, Sembo I, ­Redlund-Johnell I, Dawson A et al (2000) Long-term risk of osteoporotic fracture in Malmo. Osteoporos Int 11(8):669–674. Epub 2000/11/30

    Article  PubMed  CAS  Google Scholar 

  4. Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL (1992) Perspective. How many women have osteoporosis? J Bone Miner Res 7(9):1005–1010. Epub 1992/09/01

    Article  PubMed  Google Scholar 

  5. Johnell O, Kanis J (2005) Epidemiology of osteoporotic fractures. Osteoporos Int 16(Suppl 2):S3–S7. Epub 2004/09/15

    Article  PubMed  Google Scholar 

  6. Vestergaard P, Rejnmark L, Mosekilde L (2005) Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int 16(2):134–141. Epub 2004/06/16

    Article  PubMed  Google Scholar 

  7. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P et al (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185–1194. Epub 2005/06/09

    Article  PubMed  Google Scholar 

  8. Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259. Epub 1996/05/18

    Article  PubMed  CAS  Google Scholar 

  9. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M (2000) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15(4):721–739. Epub 2000/04/26

    Article  PubMed  CAS  Google Scholar 

  10. Gehlbach S, Saag KG, Adachi JD, Hooven FH, Flahive J, Boonen S et al (2012) Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women. J Bone Miner Res 27(3):645–653. Epub 2011/11/25

    Article  PubMed  Google Scholar 

  11. Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P (2009) Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977–2001. J Bone Miner Res 24(7):1299–1307. Epub 2009/03/05

    Article  PubMed  Google Scholar 

  12. DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group (2010) Patient level pooled analysis of 68,500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 340:b5463. Epub 2010/01/14

    Article  Google Scholar 

  13. Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 348(9041):1535–1541. Epub 1996/12/07

    Article  PubMed  CAS  Google Scholar 

  14. Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA et al (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280(24):2077–2082. Epub 1999/01/06

    Article  PubMed  CAS  Google Scholar 

  15. Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11(1):83–91. Epub 2000/02/09

    Article  PubMed  CAS  Google Scholar 

  16. Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M et al (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282(14):1344–1352. Epub 1999/10/20

    Article  PubMed  CAS  Google Scholar 

  17. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344(5):333–340. Epub 2001/02/15

    Article  PubMed  CAS  Google Scholar 

  18. Chesnut IC, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A et al (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 19(8):1241–1249. Epub 2004/07/03

    Article  CAS  Google Scholar 

  19. Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809–1822. Epub 2007/05/04

    Article  PubMed  CAS  Google Scholar 

  20. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809. Epub 2007/09/20

    Article  PubMed  CAS  Google Scholar 

  21. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282(7):637–645. Epub 1999/10/12

    Article  PubMed  CAS  Google Scholar 

  22. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361(8):756–765. Epub 2009/08/13

    Article  PubMed  CAS  Google Scholar 

  23. Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C et al (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90(5):2816–2822. Epub 2005/02/25

    Article  PubMed  CAS  Google Scholar 

  24. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350(5):459–468. Epub 2004/01/30

    Article  PubMed  CAS  Google Scholar 

  25. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY et al (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434–1441. Epub 2001/05/11

    Article  PubMed  CAS  Google Scholar 

  26. Greenspan SL, Bone HG, Ettinger MP, Hanley DA, Lindsay R, Zanchetta JR et al (2007) Effect of ­recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146(5):326–339. Epub 2007/03/07

    Article  PubMed  Google Scholar 

  27. Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ et al (2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA 290(13):1729–1738. Epub 2003/10/02

    Article  PubMed  CAS  Google Scholar 

  28. Jamoulle M (1986) Information et informtisation en médecine générale. In: Berleur J, Labet-Maris CL, Poswick RF, Valenduc G, Van Bastelaer P (eds) Les informagiciens. Presses Universitaires de Namur, Namur, pp 193–209

    Google Scholar 

  29. Jamoulle M (2012) Quaternary prevention – prevention as you never heard before. Available from http://www.ulb.ac.be/esp/mfsp/quat-en.html. Accessed 01 Jan 2013

  30. Bahl S, Coates PS, Greenspan SL (2003) The ­management of osteoporosis following hip fracture: have we improved our care? Osteoporos Int 14(11):884–888. Epub 2003/10/22

    Article  PubMed  Google Scholar 

  31. Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T (2003) Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 163(18):2165–2172. Epub 2003/10/15

    Article  PubMed  Google Scholar 

  32. Juby AG, De Geus-Wenceslau CM (2002) Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporos Int 13(3):205–210. Epub 2002/05/07

    Article  PubMed  CAS  Google Scholar 

  33. Gregersen M, Morch MM, Hougaard K, Damsgaard EM (2012) Geriatric intervention in elderly patients with hip fracture in an orthopedic ward. J Inj Violence Res 4(2):45–51. Epub 2011/04/20

    Article  PubMed  Google Scholar 

  34. Murray AW, McQuillan C, Kennon B, Gallacher SJ (2005) Osteoporosis risk assessment and treatment intervention after hip or shoulder fracture. Injury 36(9):1080–1084. Epub 2005/07/30

    Article  PubMed  CAS  Google Scholar 

  35. Harrington JT, Lease J (2007) Osteoporosis disease management for fragility fracture patients: new ­understandings based on three years’ experience with an osteoporosis care service. Arthritis Rheum 57(8):1502–1506. Epub 2007/12/01

    Article  PubMed  Google Scholar 

  36. Wallace I, Callachand F, Elliott J, Gardiner P (2011) An evaluation of an enhanced fracture liaison service as the optimal model for secondary prevention of osteoporosis. JRSM Short Rep 2(2):8. Epub 2011/03/04

    Article  PubMed  Google Scholar 

  37. Inderjeeth CA, Glennon DA, Poland KE, Ingram KV, Prince RL, Van VR et al (2010) A multimodal ­intervention to improve fragility fracture management in patients presenting to emergency departments. Med J Aust 193(3):149–153. Epub 2010/08/04

    PubMed  Google Scholar 

  38. Gardner MJ, Flik KR, Mooar P, Lane JM (2002) Improvement in the undertreatment of osteoporosis following hip fracture. J Bone Joint Surg Am 84-A(8):1342–1348. Epub 2002/08/15

    PubMed  Google Scholar 

  39. Jachna CM, Whittle J, Lukert B, Graves L, Bhargava T (2003) Effect of hospitalist consultation on treatment of osteoporosis in hip fracture patients. Osteoporos Int 14(8):665–671. Epub 2003/07/25

    Article  PubMed  Google Scholar 

  40. Sidwell AI, Wilkinson TJ, Hanger HC (2004) Secondary prevention of fractures in older people: evaluation of a protocol for the investigation and treatment of osteoporosis. Intern Med J 34(3):129–132. Epub 2004/03/20

    Article  PubMed  CAS  Google Scholar 

  41. Che M, Ettinger B, Liang J, Pressman AR, Johnston J (2006) Outcomes of a disease-management program for patients with recent osteoporotic fracture. Osteoporos Int 17(6):847–854. Epub 2006/03/30

    Article  PubMed  CAS  Google Scholar 

  42. Jacobsen IB, Wiboe L, Mogensen CB (2002) [Osteoporosis prevention in patients with low energy hip fractures hospitalized in the orthopedic department]. Ugeskr Laeger 164(27):3541–3544. Epub 2002/07/16. Osteoporoseprofylakse hos patienter indlagt med hoftenaere lavenergifrakturer pa ortopaedkirurgisk afdeling

    PubMed  Google Scholar 

  43. Wiboe L, Jacobsen IB, Mogensen CB (2002) [Osteoporosis prevention in general practice after hospitalization for hip fracture]. Ugeskr Laeger 164(20):2610–2613. Epub 2002/06/05. Osteoporo­seprofylakse i almen praksis efter indlaeggelse for hoftenaer fraktur

    PubMed  Google Scholar 

  44. Sheehan J, Mohamed F, Reilly M, Perry IJ (2000) Secondary prevention following fractured neck of femur: a survey of orthopaedic surgeons practice. Ir Med J 93(4):105–107. Epub 2000/10/19

    PubMed  CAS  Google Scholar 

  45. Kamel HK, Hussain MS, Tariq S, Perry HM, Morley JE (2000) Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med 109(4):326–328. Epub 2000/09/21, PubMed 10996585

    Article  PubMed  CAS  Google Scholar 

  46. Staeger P, Burnand B, Santos-Eggimann B, Klay M, Siffert C, Livio JJ et al (2000) Prevention of recurrent hip fracture. Aging (Milano) 12(1):13–21. Epub 2000/04/04

    CAS  Google Scholar 

  47. Consensus development conference: prophylaxis and treatment of osteoporosis (1991) Am J Med 90(1):107–10. Epub 1991/01/01

    Google Scholar 

  48. Krug R, Burghardt AJ, Majumdar S, Link TM (2010) High-resolution imaging techniques for the assessment of osteoporosis. Radiol Clin North Am 48(3):601–621. Epub 2010/07/09

    Article  PubMed  Google Scholar 

  49. Guglielmi G, Muscarella S, Bazzocchi A (2011) Integrated imaging approach to osteoporosis: state-­of-the-art review and update. Radiographics 31(5):1343–1364. Epub 2011/09/16

    Article  PubMed  Google Scholar 

  50. Scharla SH, Wolf S, Dull R, Lempert UG (1999) Prevalence of low bone mass and endocrine disorders in hip fracture patients in Southern Germany. Exp Clin Endocrinol Diabetes 107(8):547–554. Epub 1999/12/28

    Article  PubMed  CAS  Google Scholar 

  51. Sharma S, Fraser M, Lovell F, Reece A, McLellan AR (2008) Characteristics of males over 50 years who present with a fracture: epidemiology and underlying risk factors. J Bone Joint Surg Br 90(1):72–77. Epub 2007/12/28

    Article  PubMed  CAS  Google Scholar 

  52. Ekman A, Michaelsson K, Petren-Mallmin M, Ljunghall S, Mallmin H (2001) DXA of the hip and heel ultrasound but not densitometry of the fingers can discriminate female hip fracture patients from controls: a comparison between four different methods. Osteoporos Int 12(3):185–191. Epub 2001/04/24

    Article  PubMed  CAS  Google Scholar 

  53. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA et al (2005) Hip fracture in women without osteoporosis. J Clin Endocrinol Metab 90(5):2787–2793. Epub 2005/02/25

    Article  PubMed  CAS  Google Scholar 

  54. McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14(12):1028–1034. Epub 2003/11/06

    Article  PubMed  Google Scholar 

  55. Hasserius R, Johnell O, Nilsson BE, Thorngren KG, Jonsson K, Mellstrom D et al (2003) Hip fracture patients have more vertebral deformities than subjects in population-based studies. Bone 32(2):180–184. Epub 2003/03/14

    Article  PubMed  CAS  Google Scholar 

  56. Takahashi M, Kushida K, Naitou K (1999) The degree of osteoporosis in patients with vertebral fracture and patients with hip fracture: relationship to incidence of vertebral fracture. J Bone Miner Metab 17(3):187–194. Epub 2000/04/11

    Article  PubMed  CAS  Google Scholar 

  57. Hutchinson TA, Polansky SM, Feinstein AR (1979) Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet 2(8145):705–709. Epub 1979/10/06

    Article  PubMed  CAS  Google Scholar 

  58. Howat I, Carty D, Harrison J, Fraser M, McLellan AR (2007) Vertebral fracture assessment in patients presenting with incident nonvertebral fractures. Clin Endocrinol (Oxf) 67(6):923–930. Epub 2007/09/07

    Article  Google Scholar 

  59. Vega E, Mautalen C, Gomez H, Garrido A, Melo L, Sahores AO (1991) Bone mineral density in patients with cervical and trochanteric fractures of the proximal femur. Osteoporos Int 1(2):81–86. Epub 1991/02/01

    Article  PubMed  CAS  Google Scholar 

  60. del Rio L, Peris P, Jover L, Guanabens N, Monegal A, Di Gregorio S (2008) Men suffer vertebral fractures with similar spinal T-scores to women. Clin Exp Rheumatol 26(2):283–287. Epub 2008/06/21

    PubMed  Google Scholar 

  61. Nolla JM, Gomez-Vaquero C, Fiter J, Roig Vilaseca D, Mateo L, Rozadilla A et al (2002) Usefulness of bone densitometry in postmenopausal women with clinically diagnosed vertebral fractures. Ann Rheum Dis 61(1):73–75. Epub 2002/01/10

    Article  PubMed  CAS  Google Scholar 

  62. Lashin H, Davie MW (2008) DXA scanning in women over 50 years with distal forearm fracture shows osteoporosis is infrequent until age 65 years. Int J Clin Pract 62(3):388–393. Epub 2007/05/31

    Article  PubMed  CAS  Google Scholar 

  63. Jutberger H, Sinclair H, Malmqvist B, Obrant K (2003) [Screening for postmenopausal osteoporosis. Women with distal radius fractures should be evaluated for bone density]. Lakartidningen 100(1–2):31–34. Epub 2003/02/08. Utredning av postmenopausal osteoporos. Kvinnor med distal radiusfraktur bor bentathetsmatas

    PubMed  Google Scholar 

  64. Kanterewicz E, Yanez A, Perez-Pons A, Codony I, Del Rio L, Diez-Perez A (2002) Association between Colles’ fracture and low bone mass: age-based differences in postmenopausal women. Osteoporos Int 13(10):824–828. Epub 2002/10/16

    Article  PubMed  CAS  Google Scholar 

  65. Tuck SP, Raj N, Summers GD (2002) Is distal forearm fracture in men due to osteoporosis? Osteoporos Int 13(8):630–636. Epub 2002/08/16

    Article  PubMed  CAS  Google Scholar 

  66. Ryan PJ (2001) Bone densitometry in the management of Colles’ fractures: which site to measure? Br J Radiol 74(888):1137–1141. Epub 2002/01/05

    PubMed  CAS  Google Scholar 

  67. Vestergaard P, Rejnmark L, Mosekilde L (2007) Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int 18(12):1583–1593. Epub 2007/06/15

    Article  PubMed  CAS  Google Scholar 

  68. Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C et al (2004) Mortality after osteoporotic fractures. Osteoporos Int 15(1):38–42. Epub 2003/11/01

    Article  PubMed  CAS  Google Scholar 

  69. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B, Oglesby AK (2003) The components of excess mortality after hip fracture. Bone 32(5):468–473. Epub 2003/05/20

    Article  PubMed  CAS  Google Scholar 

  70. Tosteson AN, Gottlieb DJ, Radley DC, Fisher ES, Melton LJ 3rd (2007) Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int 18(11):1463–1472. Epub 2007/08/30

    Article  PubMed  CAS  Google Scholar 

  71. Jalava T, Sarna S, Pylkkanen L, Mawer B, Kanis JA, Selby P et al (2003) Association between vertebral fracture and increased mortality in osteoporotic patients. J Bone Miner Res 18(7):1254–1260. Epub 2003/07/12

    Article  PubMed  Google Scholar 

  72. Brenneman SK, Barrett-Connor E, Sajjan S, Markson LE, Siris ES (2006) Impact of recent fracture on health-related quality of life in postmenopausal women. J Bone Miner Res 21(6):809–816. Epub 2006/06/07

    Article  PubMed  Google Scholar 

  73. Papaioannou A, Kennedy CC, Ioannidis G, Sawka A, Hopman WM, Pickard L et al (2009) The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int 20(5):703–714. Epub 2008/09/20

    Article  PubMed  CAS  Google Scholar 

  74. Strom O, Borgstrom F, Zethraeus N, Johnell O, Lidgren L, Ponzer S et al (2008) Long-term cost and effect on quality of life of osteoporosis-related fractures in Sweden. Acta Orthop 79(2):269–280. Epub 2008/05/20

    Article  PubMed  Google Scholar 

  75. Ryg J (2009) The frail hip – a study on the risk of second hip fracture, prevalence of osteoporosis and adherence to treatment in patients with recent hip fracture. University of Southern Denmark

    Google Scholar 

  76. Fink HA, Harrison SL, Taylor BC, Cummings SR, Schousboe JT, Kuskowski MA et al (2008) Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine: study of osteoporotic fractures. J Clin Densitom 11(2):250–259. Epub 2008/02/26

    Article  PubMed  Google Scholar 

  77. Siris ES, Brenneman SK, Barrett-Connor E, Miller PD, Sajjan S, Berger ML et al (2006) The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50–99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int 17(4):565–574. Epub 2006/01/05

    Article  PubMed  CAS  Google Scholar 

  78. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V et al (2008) Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (1):CD001155. Epub 2008/02/07

    Google Scholar 

  79. Wells G, Cranney A, Peterson J, Boucher M, Shea B, Robinson V et al (2008) Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (1):CD004523. Epub 2008/02/07

    Google Scholar 

  80. Recker R, Stakkestad JA, Chesnut CH 3rd, Christiansen C, Skag A, Hoiseth A et al (2004) Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis. Bone 34(5):890–899. Epub 2004/05/04

    Article  PubMed  CAS  Google Scholar 

  81. Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML et al (2008) Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum 58(6):1687–1695. Epub 2008/06/03

    Article  PubMed  CAS  Google Scholar 

  82. Brumsen C, Papapoulos SE, Lips P, Geelhoed-Duijvestijn PH, Hamdy NA, Landman JO et al (2002) Daily oral pamidronate in women and men with osteoporosis: a 3-year randomized placebo-controlled clinical trial with a 2-year open extension. J Bone Miner Res 17(6):1057–1064. Epub 2002/06/11

    Article  PubMed  CAS  Google Scholar 

  83. Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V et al (2008) Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev (1):CD003376. Epub 2008/02/07

    Google Scholar 

  84. Sale JE, Beaton D, Posen J, Elliot-Gibson V, Bogoch E (2011) Systematic review on interventions to improve osteoporosis investigation and treatment in fragility fracture patients. Osteoporos Int 22(7):2067–2082. Epub 2011/05/25

    Article  PubMed  CAS  Google Scholar 

  85. Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M et al (2003) Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med 163(17):2052–2057. Epub 2003/09/25

    Article  PubMed  Google Scholar 

  86. Huntjens KM, van Geel TC, Geusens PP, Winkens B, Willems P, van den Bergh J et al (2011) Impact of guideline implementation by a fracture nurse on subsequent fractures and mortality in patients presenting with non-vertebral fractures. Injury 42(Suppl 4):S39–S43. Epub 2011/10/05

    Article  PubMed  Google Scholar 

  87. Harrington JT, Broy SB, Derosa AM, Licata AA, Shewmon DA (2002) Hip fracture patients are not treated for osteoporosis: a call to action. Arthritis Rheum 47(6):651–654. Epub 2003/01/11

    Article  PubMed  Google Scholar 

  88. Siris ES, Bilezikian JP, Rubin MR, Black DM, Bockman RS, Bone HG et al (2003) Pins and plaster aren’t enough: a call for the evaluation and treatment of patients with osteoporotic fractures. J Clin Endocrinol Metab 88(8):3482–3486. Epub 2003/08/14

    Article  PubMed  CAS  Google Scholar 

  89. Bogoch ER, Elliot-Gibson V, Beaton DE, Jamal SA, Josse RG, Murray TM (2006) Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am 88(1):25–34. Epub 2006/01/05

    Article  PubMed  Google Scholar 

  90. Little EA, Eccles MP (2010) A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis. Implement Sci 5:80. Epub 2010/10/26

    Article  PubMed  Google Scholar 

  91. Marsh D, Akesson K, Beaton DE, Bogoch ER, Boonen S, Brandi ML et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22(7):2051–2065. Epub 2011/05/25

    Article  PubMed  CAS  Google Scholar 

  92. Charalambous CP, Mosey C, Johnstone E, Akimau P, Gullett TK, Siddique I et al (2009) Improving osteoporosis assessment in the fracture clinic. Ann R Coll Surg Engl 91(7):596–598. Epub 2009/06/30

    Article  PubMed  CAS  Google Scholar 

  93. Gardner MJ, Brophy RH, Demetrakopoulos D, Koob J, Hong R, Rana A et al (2005) Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial. J Bone Joint Surg Am 87(1):3–7. Epub 2005/01/07

    Article  PubMed  Google Scholar 

  94. Hawker G, Ridout R, Ricupero M, Jaglal S, Bogoch E (2003) The impact of a simple fracture clinic intervention in improving the diagnosis and treatment of osteoporosis in fragility fracture patients. Osteoporos Int 14(2):171–178. Epub 2003/05/06

    PubMed  Google Scholar 

  95. Bliuc D, Eisman JA, Center JR (2006) A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures. Osteoporos Int 17(9):1309–1317. Epub 2006/06/29

    Article  PubMed  CAS  Google Scholar 

  96. Feldstein A, Elmer PJ, Smith DH, Herson M, Orwoll E, Chen C et al (2006) Electronic medical record reminder improves osteoporosis management after a fracture: a randomized, controlled trial. J Am Geriatr Soc 54(3):450–457. Epub 2006/03/23

    Article  PubMed  Google Scholar 

  97. Majumdar SR, Rowe BH, Folk D, Johnson JA, Holroyd BH, Morrish DW et al (2004) A controlled trial to increase detection and treatment of osteoporosis in older patients with a wrist fracture. Ann Intern Med 141(5):366–373. Epub 2004/09/09

    Article  PubMed  Google Scholar 

  98. Ashe M, Khan K, Guy P, Kruse K, Hughes K, O’Brien P et al (2004) Wristwatch-distal radial fracture as a marker for osteoporosis investigation: a controlled trial of patient education and a physician alerting system. J Hand Ther 17(3):324–328. Epub 2004/07/27

    Article  PubMed  Google Scholar 

  99. Malochet-Guinamand S, Chalard N, Billault C, Breuil N, Ristori JM, Schmidt J (2005) Osteoporosis treatment in postmenopausal women after peripheral fractures: impact of information to general practitioners. Joint Bone Spine 72(6):562–566. Epub 2005/07/06

    Article  PubMed  Google Scholar 

  100. Fraser M, McLellan AR (2004) A fracture liaison service for patients with osteoporotic fractures. Prof Nurse 19(5):286–290. Epub 2004/01/24

    PubMed  Google Scholar 

  101. Feldstein AC, Vollmer WM, Smith DH, Petrik A, Schneider J, Glauber H et al (2007) An outreach ­program improved osteoporosis management after a fracture. J Am Geriatr Soc 55(9):1464–1469. Epub 2007/10/05

    Article  PubMed  Google Scholar 

  102. Blonk MC, Erdtsieck RJ, Wernekinck MG, Schoon EJ (2007) The fracture and osteoporosis clinic: 1-year results and 3-month compliance. Bone 40(6):1643–1649. Epub 2007/04/17

    Article  PubMed  Google Scholar 

  103. Premaor MO, Pilbrow L, Tonkin C, Adams M, Parker RA, Compston J (2010) Low rates of ­treatment in postmenopausal women with a history of low trauma fractures: results of audit in a Fracture Liaison Service. QJM 103(1):33–40. Epub 2009/10/30

    Article  PubMed  CAS  Google Scholar 

  104. Majumdar SR, Beaupre LA, Harley CH, Hanley DA, Lier DA, Juby AG et al (2007) Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial. Arch Intern Med 167(19):2110–2115. Epub 2007/10/24

    Article  PubMed  Google Scholar 

  105. Eisman JA, Bogoch ER, Dell R, Harrington JT, McKinney RE Jr, McLellan A et al (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27(10):2039–2046. Epub 2012/07/28

    Article  PubMed  Google Scholar 

  106. Ankjaer-Jensen A, Johnell O (1996) Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments. Osteoporos Int 6(4):265–275. Epub 1996/01/01

    Article  PubMed  CAS  Google Scholar 

  107. Borgstrom F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O et al (2006) Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 17(5):637–650. Epub 2005/11/12

    Article  PubMed  Google Scholar 

  108. Zethraeus N, Stromberg L, Jonsson B, Svensson O, Ohlen G (1997) The cost of a hip fracture estimates for 1,709 patients in Sweden. Acta Orthop Scand 68(1):13–17. Epub 1997/02/01

    Article  PubMed  CAS  Google Scholar 

  109. Gandjour A, Weyler EJ (2006) Cost-effectiveness of referrals to high-volume hospitals: an analysis based on a probabilistic Markov model for hip fracture surgeries. Health Care Manag Sci 9(4):359–369. Epub 2006/12/26

    Article  PubMed  Google Scholar 

  110. McLellan AR, Wolowacz SE, Zimovetz EA, Beard SM, Lock S, McCrink L et al (2011) Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision. Osteoporos Int 22(7):2083–2098. Epub 2011/05/25

    Article  PubMed  CAS  Google Scholar 

  111. Sander B, Elliot-Gibson V, Beaton DE, Bogoch ER, Maetzel A (2008) A coordinator program in post-fracture osteoporosis management improves outcomes and saves costs. J Bone Joint Surg Am 90(6):1197–1205. Epub 2008/06/04

    Article  PubMed  Google Scholar 

  112. Brixen K, Overgaard S, Gram J, Ryg J, Rothmann M, Gudex C et al (2012) Systematic prevention and treatment of osteoporosis in patients with hip fractures – a health technology assessment (Danish). Danish Health and Medicines Authority, Danish Centre of Health Technology Assessment (DACEHTA), Copenhagen

    Google Scholar 

  113. Cooper MS, Palmer AJ, Seibel MJ (2012) Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study. Osteoporos Int 23(1):97–107. Epub 2011/09/29

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Odense University Hospital, University of Southern Denmark, DK-5000, Odense C, Denmark

    Kim Brixen & Mette Rothmann

  2. Department of Orthopaedic Surgery and Traumatology, Odense University Hospital, University of Southern Denmark, DK-5000, Odense C, Denmark

    Søren Overgaard

  3. Department of Endocrinology, Hospital of Southwest Denmark, DK-6700, Esbjerg, Denmark

    Jeppe Gram

  4. Department of Geriatrics, Odense University Hospital, University of Southern Denmark, DK-5000, Odense C, Denmark

    Jesper Ryg

  5. Department of Endocrinology, Odense University Hospital, DK-5000, Odense C, Denmark

    Claire Gudex

  6. Centre for Applied Health Services Research and Technology Assessment, University of Southern Denmark, DK-5000, Odense C, Denmark

    Jan Sørensen

Authors
  1. Kim Brixen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Søren Overgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeppe Gram
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jesper Ryg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mette Rothmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Claire Gudex
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jan Sørensen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kim Brixen .

Editor information

Editors and Affiliations

  1. Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, HA7 4LP, Middlesex, United Kingdom

    George Bentley

Rights and permissions

Reprints and permissions

Copyright information

© 2013 EFORT

About this chapter

Cite this chapter

Brixen, K. et al. (2013). Evidence for Medical Treatment for Tertiary Prophylaxis of Osteoporosis. In: Bentley, G. (eds) European Instructional Lectures. European Instructional Lectures, vol 13. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36149-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-36149-4_1

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-36148-7

  • Online ISBN: 978-3-642-36149-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation